Yazar "Üçvet, Ahmet" seçeneğine göre listele

Listeleniyor 1 - 5 / 5
  • Küçük Resim Yok
    Öğe
    Chest wall resection for lung cancer: A 12-year experience in a single center
    (European Respiratory Soc Journals Ltd, 2021) Üçvet, Ahmet; Batıhan, Güntug; Yazgan, Serkan; Ceylan, Kenan Can; Gürsoy, Soner; Kaya, Şeyda Örs
    [Abstract Not Available]
  • Küçük Resim
    Öğe
    Iterative surgical resections in non-small cell lung cancer
    (Termedia Publishing House Ltd, 2021) Üçvet, Ahmet; Yazgan, Serkan; Samancılar, Özgür; Gürsoy, Soner; Erbaycu, Ahmet Emin; Kömürcüoğlu, Berna
    Introduction: We reviewed our surgical preferences and the prognosis for recurrent and second primary tumors in patients who underwent surgical treatment for non-small cell lung carcinoma (NSCLC). Aim: We report our experience with patients undergoing iterative pulmonary resection for lung cancer. Material and methods: Among patients who underwent anatomical resection for primary NSCLC, those who underwent a second surgical resection between 2010 and 2020 due to recurrent or second primary tumor were included in the study. Operative mortality, survival, and prognostic factors were investigated. Results: In total, 77 cases were included: 31 (40.3%) underwent the second resection for the recurrent disease and 46 (59.7%) underwent the second resection for the second primary tumor. Postoperative mortality occurred in 8 (10.4%) patients. All patients with postoperative mortality were in the group that underwent thoracotomy in both surgical procedures. The 5-year survival rate was 46.5%. The 5-year survival of those operated on for recurrent or second primary tumor was 32.8% and 51.1%, respectively (p = 0.81). The 5-year survival rate was 68.8% in patients under the age of 60 years, while it was 27.5% in patients aged 60 years and above (p = 0.004). The 5-year survival was 21.8% in patients with an interval of 36 months or less between two operations and 72.2% in those with a longer interval (p = 0.028). Conclusions: Our study shows that survival results similar to or better than primary NSCLC surgery can be obtained with lower mortality if more limited resections are performed via video-assisted thoracic surgery, especially in young patients. In addition, the prognosis is better in patients with an interval of more than 36 months between two operations.
  • Küçük Resim Yok
    Öğe
    Iterative surgical resections in non-small cell lung carcinoma
    (European Respiratory Soc Journals Ltd, 2021) Üçvet, Ahmet; Yazgan, Serkan; Samancılar, Özgür; Gürsoy, Soner; Erbaycu, Ahmet Emin; Kömürcüoğlu, Berna
    [Abstract Not Available]
  • Küçük Resim Yok
    Öğe
    Surgical and survival outcomes of sleeve lobectomy after neoadjuvant theraphy in lung cancer: With group of 265 patients
    (European Respiratory Soc Journals Ltd, 2021) Ceylan, Kenan Can; Üçvet, Ahmet; Arabacı, Bengisu; Yazgan, Serkan; Gürsoy, Soner
    [Abstract Not Available]
  • Küçük Resim
    Öğe
    Video-assisted thoracoscopic lobectomy and bilobectomy versus open thoracotomy for non-small cell lung cancer: Mortality and survival
    (Baycinar Medical Publ-Baycinar Tibbi Yayincilik, 2022) Üçvet, Ahmet; Yazgan, Serkan; Samancılar, Özgür; Türk, Yunus; Gürsoy, Soner; Erbaycu, Ahmet Emin
    Background: In this study, we aimed to evaluate patients who had non-small cell lung cancer and underwent resection, to investigate our tendency to prefer video-assisted thoracic surgery or open thoracotomy, and to compare 30-and 90-day mortalities and survival rates. Methods: Between January 2013 and January 2019, a total of 706 patients (577 males, 129 females; mean age: 61.9 +/- 8.6 years; range, 17 to 84 years) who underwent lobectomy or bilobectomy due to primary non-small cell lung cancer were retrospectively analyzed. The patients were divided into two groups as operated on through video-assisted thoracic surgery and through open thoracotomy. The 30-and 90-day mortality rates and survival rates were compared. Results: Of the patients, 202 (28.6%) underwent video-assisted thoracic surgery and 504 (71.4%) underwent open thoracotomy. Lobectomy was performed in 632 patients (89.5%) and bilobectomy was performed in 74 patients (10.5%). Patients who were chosen for video-assisted thoracic surgery were statistically significantly older, did not require any procedure other than lobectomy, did not receive neoadjuvant therapy, had a small tumor, and did not have lymph node metastases. The 30-and 90-day mortality rates in the video-assisted thoracic surgery and open thoracotomy groups were 1.8% vs. 2% and 2.6% vs. 2.5%, respectively. The five-year survival rates of video-assisted thoracic surgery and open thoracotomy groups were 74.1% and 65.2%, respectively (p>0.05). The 30-and 90-day mortality and five-year survival rates were 2.1%, 2.6%, and 73.5% in the video-assisted thoracic surgery group and 2.1%, 2.1%, and 68.5% in the open thoracotomy group, respectively, indicating no statistically significant difference between the two groups. Conclusion: Throughout the study period, video-assisted thoracic surgery was more preferred in patients with advanced age, in those who had a small tumor, who did not receive neoadjuvant therapy, did not have lymph node metastasis, and did not require any procedure other than lobectomy. In the video-assisted thoracic surgery and open thoracotomy groups, 30-and 90-day mortality and five-year survival rates were similar. Based on these findings, both procedures seem to be acceptable in this patient population.